Acthar Gel (repository corticotropin injection) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with flare-ups (sudden worsening of symptoms) of multiple sclerosis (MS).

Ampyra (dalfampridine) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to improve walking in adults with multiple sclerosis (MS).

Aubagio (teriflunomide) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple sclerosis.

Avonex (interferon beta 1a) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis (MS).

Bafiertam (monomethyl fumarate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple sclerosis (MS).

Betaseron (interferon beta-1b) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis.

Briumvi (ublituximab-xiiy) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis (MS).

Copaxone (glatiramer acetate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple sclerosis.

Fleqsuvy (baclofen) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat spasticity (muscle stiffness and spasms) resulting from multiple sclerosis in adults and children 12 years of age and older.

Gilenya (fingolimod) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis (MS) in adults and children 10 years and older.

Kesimpta (ofatumumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple sclerosis (MS).

Lemtrada (alemtuzumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple sclerosis (MS).

Mavenclad (cladribine) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis (MS).

Mayzent (siponimod) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis in adults.

Medrol (methylprednisolone) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating acute multiple sclerosis flare-ups (sudden worsening of symptoms of multiple sclerosis).

Ocrevus (ocrelizumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS).

Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS).

Ozobax DS (baclofen) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating spasticity (muscle stiffness and spasms) resulting from multiple sclerosis (MS).

Plegridy (peginterferon beta 1a) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis in adults.

Ponvory (ponesimod) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis.

Rebif (interferon beta-1a) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple sclerosis.

Solu-Medrol (methylprednisolone sodium succinate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with acute multiple sclerosis (MS) flare-ups.

Tascenso ODT (fingolimod) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating relapsing (returning) forms of multiple sclerosis in people ages 10 years and older.

Tecfidera (dimethyl fumarate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple sclerosis.

Tyruko (natalizumab-sztn) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis in adults.

Tysabri (natalizumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis.

Vumerity (diroximel fumarate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis in adults.

Zeposia (ozanimod) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis (MS).